Innovating Works

DCP

Desconocido
TTV GUIDE TX: PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION A RANDOM... Institut klinick a experimentln mediciny participó en un H2020: H2020-SC1-BHC-2018-2020 Challenge: End stage renal disease (ESRD) causes high socioeconomic burden for citizens and the healthcare system in Europe. Kidney transpla...
2021-02-02 - 2026-04-30 | Financiado
STOPSTORM: A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE ENTRANT TACHYCARDIA Institut klinick a experimentln mediciny participó en un H2020: H2020-SC1-BHC-2018-2020 Ventricular tachycardia (VT) is an unpredictable and potentially deadly condition and should be promptly treated with catheter ablation and...
2021-01-21 - 2027-04-30 | Financiado
BEAT AF: Ground BrEAking Electroporation based inTervention for Atrial Fibrillation treatment BEAT AF Institut klinick a experimentln mediciny participó en un H2020: H2020-SC1-BHC-2018-2020 Atrial fibrillation (AF), the most common arrhythmia, accounts for 1/3rd of Cardiovascular expenses, with over 10 millions affected in Europ...
2021-01-18 - 2026-02-28 | Financiado
RENAL FUNCTIONS/EETS: Role of Epoxyeicosatrienoic Acids in the Regulation of Blood Pressure Renal Hemodynamics and Sodium... Institut klinick a experimentln mediciny tramitó un FP7: Cytochrome P450 (CYP) metabolites are more frequently recognized as important regulators of cardiovascular and renal functions. CYP epoxygen...
Financiado
ENCITE: European Network for Cell Imaging and Tracking Expertise Institut klinick a experimentln mediciny participó en un FP7: Cell therapy can be defined as the transplantation of living cells for the treatment of medical disorders. Three different principles underl...
Financiado
BETATRAIN: European Training Network for Excellence in Molecular Imaging in Diabetes Institut klinick a experimentln mediciny participó en un FP7: Currently, 180 million people suffer from diabetes worldwide and this number is expected to double until 2030. Diabetes-related healthcare c...
Financiado
DIAdvisor: Personal Glucose Predictive Diabetes Advisor Institut klinick a experimentln mediciny participó en un FP7: The DIAdvisor is a large scale integrating project (IP) aiming at development of a prediction based tool which uses past and easily availabl...
Financiado
EUROSTAM: A Europe wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptab... Institut klinick a experimentln mediciny participó en un FP7: The presence of donor specific HLA antibodies is a contra-indication for renal transplantation. Highly sensitized patients accumulate and of...
Financiado
MABSOT: Development of OPN 305 as an orphan drug for the treatment of Delayed Graft Function post solid orga... Institut klinick a experimentln mediciny participó en un FP7: Delayed graft function (DGF) is defined as the need for dialysis within seven days of renal transplantation (DGF promotes allograft rejectio...
Financiado
PRIORITY: Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabeti... Institut klinick a experimentln mediciny participó en un FP7: Patients with diabetes are at risk of developing diabetic nephropathy, which will ultimately result in the requirement for renal replacement...
Financiado
BIO-DrIM: Personalized minimization of immunosuppression after solid organ transplantation by biomarker driven... Institut klinick a experimentln mediciny participó en un FP7: Organ transplantation has emerged as the gold standard therapy for end-stage organ failure. Incomplete control of chronic allograft injury b...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.